New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...
In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...
Novartis spokesperson told News18 that the company is in the process of reviewing the minutes of the meeting and post ...
This year’s conference highlighted a number of critical areas in clinical R&D including financial management, representation, ...
Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed ...
The study introduces G-AUDIT (Generalized Attribute Utility and Detectability-Induced bias Testing) as a data modality-agnostic auditing tool, meaning it can be applied across different types of ...
On January 6, 2025, the US Food and Drug Administration (FDA) and the US Department of Health and Human Services (HHS) Office for Human ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed primary efficacy endpoint of reduction in bloodstream inf ...
The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.
There is insufficient evidence to support exclusive enteral nutrition as an adjunctive therapy for active ulcerative colitis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback